Personal information

Other IDs

Scopus Author ID: 23135421500

Countries

United States

Activities

Collapse all

Employment (5)

Washington University in St Louis: St Louis, MO, US

2020-09 to present | Assistant Professor (Pathology & Immunology)
Employment
Source: Self-asserted source
Kilannin Krysiak

Washington University in St Louis School of Medicine: St Louis, MO, US

2018-07-01 to 2020-06-30 | Laboratory Genetics and Genomics Fellow (Pathology & Immunology)
Employment
Source: Self-asserted source
Kilannin Krysiak

Washington University in St Louis: Saint Louis, MO, US

2016-08-01 to 2018-06-30 | Instructor in Medicine (Division of Oncology, Department of Medicine)
Employment
Source: Self-asserted source
Kilannin Krysiak

Washington University in Saint Louis: Saint Louis, MO, US

2014-07-01 to 2016-07-31 | Staff Scientist (McDonnell Genome Institute)
Employment
Source: Self-asserted source
Kilannin Krysiak

University of Illinois at Urbana-Champaign: Urbana, IL, US

2006 to 2008 | Visiting Research Specialist (Department of Chemistry)
Employment
Source: Self-asserted source
Kilannin Krysiak

Education and qualifications (3)

American Board of Medical Genetics and Genomics: Bethesda, MD, US

Qualification
Source: Self-asserted source
Kilannin Krysiak

Washington University in Saint Louis: Saint Louis, MO, US

2008 to 2014 | Ph.D. (Division of Biology and Biomedical Sciences)
Education
Source: Self-asserted source
Kilannin Krysiak

University of Illinois at Urbana-Champaign: Urbana, IL, US

2002 to 2006 | B.S. Molecular and Cellular Biology (Biology)
Education
Source: Self-asserted source
Kilannin Krysiak

Funding (3)

Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine

2019-04-02 to 2024-03-31 | Grant
National Cancer Institute (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.8388528
GRANT_NUMBER: U24CA237719
Source: Self-asserted source
Kilannin Krysiak via DimensionsWizard

DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER

Source: Self-asserted source
Kilannin Krysiak via DimensionsWizard

The Impact of Hspa9 Haploinsufficiency on Murine Hematopoiesis and Leukemogenesis

Source: Self-asserted source
Kilannin Krysiak via DimensionsWizard

Works (50 of 59)

Items per page:
Page 1 of 2

Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations

Clinical Genetics
2025-04 | Journal article
DOI: 10.1111/cge.14667
Contributors: Reza Ghasemi; Meagan M. Corliss; Kevin M. Bowling; Kilannin Krysiak; Jason Walker; Alexa M. Dickson; Molly C. Schroeder; Bijal A. Parikh; Julie A. Neidich; Katarzyna Polonis et al.
Source: check_circle
Crossref

Modified Rules for Classification of Variants Associated With Disorders of Somatic Mosaicism

Clinical Genetics
2025-03 | Journal article
DOI: 10.1111/cge.14636
Contributors: Fernando Zazueta Leon‐Quintero; Kevin M. Bowling; Alexa Dickson; Meagan M. Corliss; Molly C. Schroeder; Julie A. Neidich; Jonathan W. Heusel; Kilannin Krysiak; Katarzyna Polonis; Bijal A. Parikh et al.
Source: check_circle
Crossref

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review

JCO Precision Oncology
2025-01 | Journal article
DOI: 10.1200/PO.24.00305
Contributors: Samuel Kim; Malak Itani; Xiuli Liu; Lulu Sun; Kilannin Krysiak; Nicole Fox; Belal Firwana; Sameer Al Diffalha; Upender Manne; Andreas Seeber et al.
Source: check_circle
Crossref

A comparative analysis of RAS variants in patients with disorders of somatic mosaicism

Genetics in Medicine
2023 | Journal article
DOI: 10.1016/j.gim.2022.11.016
EID:

2-s2.0-85146628147

Part of ISSN: 15300366 10983600
Contributors: Claire Hou, Y.-C.; Evenson, M.J.; Corliss, M.M.; Mahapatra, L.; Aldawood, A.; Carpentieri, D.F.; Chamlin, S.L.; Kulungowski, A.M.; Madan-Khetarpal, S.; Sebastian, J. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Accessing clinical-grade genomic classification data through the ClinGen Data Platform

Pacific Symposium on Biocomputing
2023 | Conference paper
DOI: 10.1142/9789811270611_0048
EID:

2-s2.0-85144311192

Part of ISSN: 23356936 23356928
Contributors: Dalton, K.P.; Rehm, H.L.; Wright, M.W.; Mandell, M.E.; Krysiak, K.; Babb, L.; Riehle, K.; Nelson, T.; Wagner, A.H.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

Blood Advances
2023-09-26 | Journal article
DOI: 10.1182/bloodadvances.2023010779
Contributors: David A. Russler-Germain; Kilannin Krysiak; Cody Ramirez; Matthew Mosior; Marcus P. Watkins; Felicia Gomez; Zachary L. Skidmore; Lee Trani; Feng Gao; Susan Geyer et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research
2023-01-06 | Journal article
DOI: 10.1093/nar/gkac979
Contributors: Kilannin Krysiak; Arpad M Danos; Jason Saliba; Joshua F McMichael; Adam C Coffman; Susanna Kiwala; Erica K Barnell; Lana Sheta; Cameron J Grisdale; Lynzey Kujan et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Erratum: Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC) (Genetics in Medicine (2022) 24(5) (986–998), (S1098360022000016), (10.1016/j.gim.2022.01.001))

Genetics in Medicine
2022 | Journal article
DOI: 10.1016/j.gim.2022.07.001
EID:

2-s2.0-85137166819

Part of ISSN: 15300366 10983600
Contributors: Horak, P.; Griffith, M.; Danos, A.M.; Pitel, B.A.; Madhavan, S.; Liu, X.; Chow, C.; Williams, H.; Carmody, L.; Barrow-Laing, L. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers

Cancer Genetics
2022 | Journal article
DOI: 10.1016/j.cancergen.2022.04.002
EID:

2-s2.0-85129957433

Part of ISSN: 22107770 22107762
Contributors: Skidmore, Z.L.; Kunisaki, J.; Lin, Y.; Cotto, K.C.; Barnell, E.K.; Hundal, J.; Krysiak, K.; Magrini, V.; Trani, L.; Walker, J.R. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease

Human Mutation
2022 | Journal article
DOI: 10.1002/humu.24392
EID:

2-s2.0-85129591086

Part of ISSN: 10981004 10597794
Contributors: Chiorean, A.; Farncombe, K.M.; Delong, S.; Andric, V.; Ansar, S.; Chan, C.; Clark, K.; Danos, A.M.; Gao, Y.; Giles, R.H. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma

medRxiv
2022 | Other
DOI: 10.1101/2022.01.06.22268805
EID:

2-s2.0-85125029956
Contributors: Ramirez, C.A.; Frenkel, F.; Becker-Hapak, M.; Barnell, E.K.; McClain, E.D.; Desai, S.; Schappe, T.; Onyeador, O.C.; Kudryashova, O.; Belousov, V. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

Blood
2022 | Journal article
DOI: 10.1182/blood.2021011894
EID:

2-s2.0-85127190637

Part of ISSN: 15280020 00064971
Contributors: Ward, J.P.; Berrien-Elliott, M.M.; Gomez, F.; Luo, J.; Becker-Hapak, M.; Cashen, A.F.; Wagner-Johnston, N.D.; Maddocks, K.; Mosior, M.; Foster, M. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Genetics in Medicine
2022 | Journal article
DOI: 10.1016/j.gim.2022.01.001
EID:

2-s2.0-85123717727

Part of ISSN: 15300366 10983600
Contributors: Horak, P.; Griffith, M.; Danos, A.M.; Pitel, B.A.; Madhavan, S.; Liu, X.; Chow, C.; Williams, H.; Carmody, L.; Barrow-Laing, L. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

A community approach to the cancer-variant-interpretation bottleneck

Nature Cancer
2022-05-27 | Journal article
DOI: 10.1038/s43018-022-00379-w
Contributors: Kilannin Krysiak; Arpad M. Danos; Susanna Kiwala; Joshua F. McMichael; Adam C. Coffman; Erica K. Barnell; Lana Sheta; Jason Saliba; Cameron J. Grisdale; Lynzey Kujan et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Corrigendum to “Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice” [Leuk. Res. 96C (2020) 106428] (Leukemia Research (2020) 96, (S0145212620301338), (10.1016/j.leukres.2020.106428))

Leukemia Research
2021 | Journal article
DOI: 10.1016/j.leukres.2020.106478
EID:

2-s2.0-85097474605

Part of ISSN: 18735835 01452126
Contributors: Liu, T.; Ahmed, T.; Krysiak, K.; Shirai, C.L.; Shao, J.; Nunley, R.; Bucala, R.; McKenzie, A.; Ndonwi, M.; Walter, M.J.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers

2021-12-16 | Preprint
DOI: 10.1101/2021.12.14.472689
Contributors: Zachary L Skidmore; Jason Kunisaki; Yiing Lin; Kelsy C Cotto; Erica K Barnell; Jasreet Hundal; Kilannin Krysiak; Vincent Magrini; Lee Trani; Jason R Walker et al.
Source: check_circle
Crossref

Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia

JCO Precision Oncology
2021-11 | Journal article
DOI: 10.1200/PO.20.00182
Contributors: Erica K. Barnell; Kenneth F. Newcomer; Zachary L. Skidmore; Kilannin Krysiak; Sydney R. Anderson; Lukas D. Wartman; Stephen T. Oh; John S. Welch; Keith E. Stockerl-Goldstein; Ravi Vij et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Heterozygous HMGB1 loss‐of‐function variants are associated with developmental delay and microcephaly

Clinical Genetics
2021-10 | Journal article
DOI: 10.1111/cge.14015
Contributors: Kévin Uguen; Kilannin Krysiak; Séverine Audebert‐Bellanger; Sylvia Redon; Caroline Benech; Eléonore Viora‐Dupont; Frederic Tran Mau‐Them; Sophie Rondeau; Ibrahim Elsharkawi; Jorge L. Granadillo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma

2021-07-04 | Other
DOI: 10.1101/2021.06.25.21258374
Contributors: Felicia Gomez; Matthew Mosior; Joshua McMichael; Zachary L. Skidmore; Eric J. Duncavage; Christopher A. Miller; Haley J. Abel; Yi-Shan Li; Kilannin Krysiak; David A. Russler-Germain et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evolution of the open-access CIViC knowledgebase is driven by the needs of the cancer variant interpretation community

2021-06-14 | Other
DOI: 10.1101/2021.06.13.448171
Contributors: Kilannin Krysiak; Arpad M Danos; Susanna Kiwala; Joshua F McMichael; Adam C Coffman; Erica K Barnell; Lana Sheta; Jason Saliba; Cameron J Grisdale; Lynzey Kujan et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice.

Leukemia research
2020-07-23 | Journal article
DOI: 10.1016/j.leukres.2020.106428
PMID: 32739655
Source: Self-asserted source
Kilannin Krysiak
grade
Preferred source (of 2)‎

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Nature Genetics
2020-04-03 | Journal article
DOI: 10.1038/s41588-020-0603-8
Contributors: Alex H. Wagner; Brian Walsh; Georgia Mayfield; David Tamborero; Dmitriy Sonkin; Kilannin Krysiak; Jordi Deu-Pons; Ryan P. Duren; Jianjiong Gao; Julie McMurry et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation

Cell Reports
2019 | Journal article
DOI: 10.1016/j.celrep.2019.06.098
EID:

2-s2.0-85069896022

Part of ISSN: 22111247
Contributors: Campbell, K.M.; O'Leary, K.A.; Rugowski, D.E.; Mulligan, W.A.; Barnell, E.K.; Skidmore, Z.L.; Krysiak, K.; Griffith, M.; Schuler, L.A.; Griffith, O.L.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase

JCO Clinical Cancer Informatics
2019 | Journal article
DOI: 10.1200/CCI.19.00127
EID:

2-s2.0-85088676859

Part of ISSN: 24734276
Contributors: Wagner, A.H.; Kiwala, S.; Coffman, A.C.; McMichael, J.F.; Cotto, K.C.; Mooney, T.B.; Barnell, E.K.; Krysiak, K.; Danos, A.M.; Walker, J. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples

Genetics in Medicine
2019 | Journal article
DOI: 10.1038/s41436-018-0278-z
EID:

2-s2.0-85054557225

Part of ISSN: 15300366 10983600
Contributors: Barnell, E.K.; Ronning, P.; Campbell, K.M.; Krysiak, K.; Ainscough, B.J.; Sheta, L.M.; Pema, S.P.; Schmidt, A.D.; Richters, M.; Cotto, K.C. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Text-mining clinically relevant cancer biomarkers for curation into the CIViC database

Genome Medicine
2019 | Journal article
DOI: 10.1186/s13073-019-0686-y
EID:

2-s2.0-85076094831

Part of ISSN: 1756994X
Contributors: Lever, J.; Jones, M.R.; Danos, A.M.; Krysiak, K.; Bonakdar, M.; Grewal, J.K.; Culibrk, L.; Griffith, O.L.; Griffith, M.; Jones, S.J.M.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Tumor Heterogeneity

Cancer Genomics for the Clinician
2019 | Book chapter
EID:

2-s2.0-85134443225

ISBN: 9780826168689 9780826168672
Contributors: Wagner, A.H.; Krysiak, K.; Campbell, K.M.; Barnell, E.K.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Standard operating procedure for curation and clinical interpretation of variants in cancer.

Genome medicine
2019-11-29 | Journal article
DOI: 10.1186/s13073-019-0687-x
PMID: 31779674
PMC: PMC6883603
Source: Self-asserted source
Kilannin Krysiak
grade
Preferred source (of 2)‎

Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.

JCO clinical cancer informatics
2019-10-01 | Journal article
DOI: 10.1200/cci.19.00077
PMID: 31618044
PMC: PMC6873961
Source: Self-asserted source
Kilannin Krysiak
grade
Preferred source (of 2)‎

CIViCpy: a Python software development and analysis toolkit for the CIViC knowledgebase

2019-09-27 | Other
DOI: 10.1101/783134
Contributors: Alex H. Wagner; Susanna Kiwala; Adam C. Coffman; Joshua F. McMichael; Kelsy C. Cotto; Thomas B. Mooney; Erica K. Barnell; Kilannin Krysiak; Arpad M. Danos; Obi L. Griffith et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The CIViC knowledge model and standard operating procedures for curation and clinical interpretation of variants in cancer

2019-07-14 | Other
DOI: 10.1101/700179
Contributors: Arpad M. Danos; Kilannin Krysiak; Erica K. Barnell; Adam C. Coffman; Joshua F. McMichael; Susanna Kiwala; Nicholas C. Spies; Lana M. Sheta; Shahil P. Pema; Lynzey Kujan et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards

Human Mutation
2018 | Journal article
DOI: 10.1002/humu.23651
EID:

2-s2.0-85054667983

Part of ISSN: 10981004 10597794
Contributors: Danos, A.M.; Ritter, D.I.; Wagner, A.H.; Krysiak, K.; Sonkin, D.; Micheel, C.; McCoy, M.; Rao, S.; Raca, G.; Boca, S.M. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Text-mining clinically relevant cancer biomarkers for curation into the CIViC database

2018-12-20 | Other
DOI: 10.1101/500686
Contributors: Jake Lever; Martin R Jones; Arpad M Danos; Kilannin Krysiak; Melika Bonakdar; Jasleen Grewal; Luka Culibrk; Obi L Griffith; Malachi Griffith; Steven JM Jones
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Spontaneous aggressive ERα+ mammary tumor model is driven by Kras activation

2018-10-16 | Other
DOI: 10.1101/442624
Contributors: Katie M. Campbell; Kathleen A. O’Leary; Debra E. Rugowski; William A. Mulligan; Erica K. Barnell; Zachary L. Skidmore; Kilannin Krysiak; Malachi Griffith; Linda A. Schuler; Obi L. Griffith
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer

Nature Communications
2018-09-17 | Journal article
DOI: 10.1038/s41467-018-06162-9
Contributors: Alex H. Wagner; Siddhartha Devarakonda; Zachary L. Skidmore; Kilannin Krysiak; Avinash Ramu; Lee Trani; Jason Kunisaki; Ashiq Masood; Saiama N. Waqar; Nicholas C. Spies et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The prognostic effects of somatic mutations in ER-positive breast cancer

Nature Communications
2018-09-04 | Journal article
DOI: 10.1038/s41467-018-05914-x
Contributors: Obi L. Griffith; Nicholas C. Spies; Meenakshi Anurag; Malachi Griffith; Jingqin Luo; Dongsheng Tu; Belinda Yeo; Jason Kunisaki; Christopher A Miller; Kilannin Krysiak et al.
Source: check_circle
Crossref
grade
Preferred source (of 5)‎

A harmonized meta-knowledgebase of clinical interpretations of cancer genomic variants

2018-07-11 | Other
DOI: 10.1101/366856
Contributors: Alex H Wagner; Brian Walsh; Georgia Mayfield; David Tamborero; Dmitriy Sonkin; Kilannin Krysiak; Jordi Deu Pons; Ryan P Duren; Jianjiong Gao; Julie McMurry et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Standard operating procedure for somatic variant refinement of tumor sequencing data

2018-02-16 | Other
DOI: 10.1101/266262
Contributors: Erica K. Barnell; Peter Ronning; Katie M. Campbell; Kilannin Krysiak; Benjamin J. Ainscough; Cody Ramirez; Nick Spies; Jason Kunisaki; Jasreet Hundal; Zachary L. Skidmore et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial

Blood
2018-01-11 | Journal article
DOI: 10.1182/blood-2017-09-804641
Contributors: Nancy L. Bartlett; Brian A. Costello; Betsy R. LaPlant; Stephen M. Ansell; John G. Kuruvilla; Craig B. Reeder; Lim S. Thye; Daniel M. Anderson; Kilannin Krysiak; Cody Ramirez et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancer

Clinical Cancer Research
2017 | Journal article
DOI: 10.1158/1078-0432.CCR-17-1260
EID:

2-s2.0-85034864942

Part of ISSN: 15573265 10780432
Contributors: Ma, C.X.; Suman, V.; Goetz, M.P.; Northfelt, D.; Burkard, M.E.; Ademuyiwa, F.; Naughton, M.; Margenthaler, J.; Aft, R.; Gray, R. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer

Nature Genetics
2017 | Journal article
DOI: 10.1038/ng.3774
EID:

2-s2.0-85011275698

Part of ISSN: 15461718 10614036
Contributors: Griffith, M.; Spies, N.C.; Krysiak, K.; McMichael, J.F.; Coffman, A.C.; Danos, A.M.; Ainscough, B.J.; Ramirez, C.A.; Rieke, D.T.; Kujan, L. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

The prognostic effects of somatic mutations in ER-positive breast cancer

bioRxiv
2017 | Other
DOI: 10.1101/235846
EID:

2-s2.0-85093585237

Part of ISSN: 26928205
Contributors: Griffith, O.L.; Spies, N.C.; Anurag, M.; Griffith, M.; Luo, J.; Tu, D.; Yeo, B.; Kunisaki, J.; Miller, C.A.; Krysiak, K. et al.
Source: Self-asserted source
Kilannin Krysiak via Scopus - Elsevier

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS

Bone
2017-08 | Journal article
DOI: 10.1016/j.bone.2017.04.010
Contributors: Michael P. Whyte; Malachi Griffith; Lee Trani; Steven Mumm; Gary S. Gottesman; William H. McAlister; Kilannin Krysiak; Robert Lesurf; Zachary L. Skidmore; Katie M. Campbell et al.
Source: Self-asserted source
Kilannin Krysiak via Crossref Metadata Search
grade
Preferred source (of 2)‎

Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells

PLOS ONE
2017-02-08 | Journal article
DOI: 10.1371/journal.pone.0170470
Contributors: Tuoen Liu; Kilannin Krysiak; Cara Lunn Shirai; Sanghyun Kim; Jin Shao; Matthew Ndonwi; Matthew J. Walter; Daniel T Starczynowski
Source: Self-asserted source
Kilannin Krysiak via Crossref Metadata Search
grade
Preferred source (of 2)‎

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma

Blood
2017-01-26 | Journal article
DOI: 10.1182/blood-2016-07-729954
Contributors: Kilannin Krysiak; Felicia Gomez; Brian S. White; Matthew Matlock; Christopher A. Miller; Lee Trani; Catrina C. Fronick; Robert S. Fulton; Friederike Kreisel; Amanda F. Cashen et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.

2016 | Journal article
DOI: 10.1038/bcj.2016.18
PMID: 27058228
PMC: PMC4855253
Contributors: Krysiak K; Christopher MJ; Skidmore ZL; Demeter RT; Magrini V; Kunisaki J; O'Laughlin M; Duncavage EJ; Miller CA; Ozenberger BA et al.
Source: Self-asserted source
Kilannin Krysiak via Europe PubMed Central
grade
Preferred source (of 2)‎

Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas

Cell Reports
2016-09 | Journal article
DOI: 10.1016/j.celrep.2016.08.076
Contributors: Obi L. Griffith; Szeman Ruby Chan; Malachi Griffith; Kilannin Krysiak; Zachary L. Skidmore; Jasreet Hundal; Julie A. Allen; Cora D. Arthur; Daniele Runci; Mattia Bugatti et al.
Source: Self-asserted source
Kilannin Krysiak via Crossref Metadata Search
grade
Preferred source (of 2)‎

CIViC: A knowledgebase for expert-crowdsourcing the clinical interpretation of variants in cancer

2016-09-01 | Preprint
DOI: 10.1101/072892
Contributors: Malachi Griffith; Nicholas C Spies; Kilannin Krysiak; Adam C Coffman; Joshua F McMichael; Benjamin J Ainscough; Damian T Rieke; Arpad M Danos; Lynzey Kujan; Cody A Ramirez et al.
Source: check_circle
Crossref

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia

Experimental Hematology
2016-07 | Journal article
DOI: 10.1016/j.exphem.2016.04.011
Contributors: Malachi Griffith; Obi L. Griffith; Kilannin Krysiak; Zachary L. Skidmore; Matthew J. Christopher; Jeffery M. Klco; Avinash Ramu; Tamara L. Lamprecht; Alex H. Wagner; Katie M. Campbell et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A genomic case study of mixed fibrolamellar hepatocellular carcinoma.

2016-06 | Journal article
DOI: 10.1093/annonc/mdw135
PMID: 27029710
PMC: PMC4880064
Contributors: Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J et al.
Source: Self-asserted source
Kilannin Krysiak via Europe PubMed Central
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (1 review for 1 publication/grant)

Review activity for Leukemia (1)
How many people are using ORCID?